Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma

被引：4

作者：

Sekiya, Sho ^{[1
,2
]}

Fukuda, Junki ^{[1
,2
]}

Yamamura, Ryodai ^{[1
]}

Ooshio, Takako ^{[1
]}

Satoh, Yusuke ^{[1
]}

Kosuge, Shinya ^{[1
,2
]}

Sato, Reo ^{[1
]}

Hatanaka, Kanako C. ^{[3
]}

Hatanaka, Yutaka ^{[3
,4
]}

Mitsuhashi, Tomoko ^{[5
]}

Nakamura, Toru ^{[2
]}

Matsuno, Yoshihiro ^{[5
]}

Hirano, Satoshi ^{[2
]}

Sonoshita, Masahiro ^{[1
,6
]}

机构：

[1] Hokkaido Univ, Inst Genet Med, Div Biomed Oncol, Sapporo 0600815, Japan

[2] Hokkaido Univ, Fac Med, Dept Gastroenterol Surg 2, Sapporo, Japan

[3] Hokkaido Univ Hosp, Ctr Dev Adv Diagnost, Sapporo, Japan

[4] Hokkaido Univ Hosp, Res Div Genome Compan Diagnost, Sapporo, Japan

[5] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Japan

[6] Hokkaido Univ, Global Stn Biosurfaces & Drug Discovery, Sapporo 0600812, Japan

来源：

CANCER RESEARCH | 2023年 / 83卷 / 16期

基金：

日本学术振兴会; 日本科学技术振兴机构;

关键词：

PHASE-1; DOSE-ESCALATION; AURORA-B; CANCER; KINASE; TRAMETINIB; COOPERATE; GEMCITABINE; PROGRESSION; EXPRESSION; KRAS(G12D);

D O I：

10.1158/0008-5472.CAN-22-3762

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Significant progress has been made in understanding the pathogenesis of pancreatic ductal adenocarcinoma (PDAC) by generating and using murine models. To accelerate drug discovery by identifying novel therapeutic targets on a systemic level, here we generated a Drosophila model mimicking the alterations), which is associated with the worst prognosis in patients. The '4-hit' flies displayed epithelial transformation and decreased survival. Comprehensive genetic screening of their entire kinome revealed kinases including MEK and AURKB as therapeutic targets. Consistently, a combination of the MEK

引用

页码：2704 / 2715

页数：12

共 50 条

[31] Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Gao, Jianjun
Wang, Jiangang
Guan, Canghai
Shi, Wujiang
Dong, Qingfu
Sheng, Jialin
Zou, Xinlei
Xu, Zhaoqiang
Ge, Yifei
Huang, Ziyue
Li, Jiehan
Bao, Haolin
Xu, Yi
Cui, Yunfu
Xu, Xiaoxue
Zhong, Xiangyu
JOURNAL OF CANCER, 2024, 15 (08): : 2214 - 2228
[32] Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
Feng, Zengyu
Li, Kexian
Wu, Yulian
Peng, Chenghong
FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
[33] A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
Koay, Eugene J.
Lee, Yeonju
Cristini, Vittorio
Lowengrub, John S.
Kang, Ya'an
Lucas, F. Anthony San
Hobbs, Brian P.
Ye, Rong
Elganainy, Dalia
Almahariq, Muayad
Amer, Ahmed M.
Chatterjee, Deyali
Yan, Huaming
Park, Peter C.
Perez, MayrimV. Rios
Li, Dali
Garg, Naveen
Reiss, Kim A.
Yu, Shun
Chauhan, Anil
Zaid, Mohamed
Nikzad, Newsha
Wolff, Robert A.
Javle, Milind
Varadhachary, Gauri R.
Shroff, Rachna T.
Das, Prajnan
Lee, Jeffrey E.
Ferrari, Mauro
Maitra, Anirban
Taniguchi, Cullen M.
Kim, Michael P.
Crane, Christopher H.
Katz, Matthew H.
Wang, Huamin
Bhosale, Priya
Tamm, Eric P.
Fleming, Jason B.
CLINICAL CANCER RESEARCH, 2018, 24 (23) : 5883 - 5894
[34] Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma
Wang, Xing
Yang, Jinshou
Ren, Bo
Yang, Gang
Liu, Xiaohong
Xiao, Ruiling
Ren, Jie
Zhou, Feihan
You, Lei
Zhao, Yupei
GENES & DISEASES, 2024, 11 (06)
[35] Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
Lyu, Su Ir
Krey, Thaddaeus
Damanakis, Alexander M.
Zhao, Yue
Bruns, Christiane
Schmidt, Thomas
Popp, Felix
Quaas, Alexander
Knipper, Karl
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7539 - 7546
[36] Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response
Norgard, Robert J.
Budhani, Pratha
O'Brien, Sarah A.
Xia, Youli
Egan, Jessica N.
Flynn, Brianna
Tagore, Joshua R.
Seco, Joseph
Peet, Gregory W.
Mikucka, Ania
Wasti, Ruby
Chan, Li-Chuan
Hinkel, Melanie
Martinez-Morilla, Sandra
Pignatelli, Jeanine
Trapani, Francesca
Corse, Emily
Feng, Di
Kostyrko, Kaja
Hofmann, Marco H.
Liu, Kang
Kashyap, Abhishek S.
CANCER RESEARCH COMMUNICATIONS, 2024, 4 (06): : 1548 - 1560
[37] Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma-A Review of the Literature
Wnuk, Jakub
Strzelczyk, Joanna Katarzyna
Gisterek, Iwona
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
[38] Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Mazur, Pawel K.
Herner, Alexander
Mello, Stephano S.
Wirth, Matthias
Hausmann, Simone
Sanchez-Rivera, Francisco J.
Lofgren, Shane M.
Kuschma, Timo
Hahn, Stephan A.
Vangala, Deepak
Trajkovic-Arsic, Marija
Gupta, Aayush
Heid, Irina
Noel, Peter B.
Braren, Rickmer
Erkan, Mert
Kleeff, Joerg
Sipos, Bence
Sayles, Leanne C.
Heikenwalder, Mathias
Hessmann, Elisabeth
Ellenrieder, Volker
Esposito, Irene
Jacks, Tyler
Bradner, James E.
Khatri, Purvesh
Sweet-Cordero, E. Alejandro
Attardi, Laura D.
Schmid, Roland M.
Schneider, Guenter
Sage, Julien
Siveke, Jens T.
NATURE MEDICINE, 2015, 21 (10) : 1163 - +
[39] Analysis of lncRNA-mRNA networks after MEK1/2 inhibition based on WGCNA in pancreatic ductal adenocarcinoma
Qian, Jing
Yang, Jianxin
Liu, Xianchen
Chen, Zhiming
Yan, Xiaodi
Gu, Hongmei
Xue, Qiang
Zhou, Xingqin
Gai, Ling
Lu, Pengpeng
Shi, Yu
Yao, Ninghua
JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (04) : 3657 - 3668
[40] A combined, rational approach towards inhibition of the MEK-ERK and mTOR pathways in pancreatic ductal adenocarcinoma Promise or deja vu?
Rhim, Andrew D.
CANCER BIOLOGY & THERAPY, 2009, 8 (20) : 1902 - 1903

← 1 2 3 4 5 →